Abstract：
BACKGROUND: Despite recent advances in ostomy care, the incidence of stoma and peristomal skin complications including peristomal moisture-associated skin damage (MASD) remains as high as 80% of patients living with ostomies. We evaluated a cyanoacrylate liquid skin protectant (CLSP) for the treatment and healing of peristomal MASD in patients with an ileostomy, ileal conduit, or colostomy.
METHODS: Five patients (24-85 years old) with peristomal MASD related to an ileostomy (n = 2), ileal conduit (n = 2), or colostomy (n = 1) were evaluated in this case study. All were treated with a CLSP in an attempt to reduce peristomal MASD caused by effluent leakage, which resulted in painful denudation of the peristomal skin. All patients received 1 to 2 applications of the CLSP prior to replacement of the pouching system. Prior to CLSP application, patients underwent assessment focusing on the causes of ostomy pouching system undermining and leakage. Interventions to prevent recurrent undermining and leakage, usually focused on modifications of the pouching system, were completed when indicated.
CONCLUSIONS: For these 5 patients, complete resolution of peristomal MASD was observed at 2 to 8 days following CLSP treatment. More severe peristomal MASD cases required 7 to 8 days for complete resolution while less severe peristomal MASD resolved within 2 to 3 days. Patients showed less frequent pouching system changes, healing of peristomal skin, and reduced peristomal MASD associated with the CLSP treatment and addressing underlying etiology. On a pain scale of 0 to 10, patients reported less pain with an average of more than 7 out of 10 prior to the CLSP treatment and less than 4 out of 10 after treatment.
METHODS: Five patients (24-85 years old) with peristomal MASD related to an ileostomy (n = 2), ileal conduit (n = 2), or colostomy (n = 1) were evaluated in this case study. All were treated with a CLSP in an attempt to reduce peristomal MASD caused by effluent leakage, which resulted in painful denudation of the peristomal skin. All patients received 1 to 2 applications of the CLSP prior to replacement of the pouching system. Prior to CLSP application, patients underwent assessment focusing on the causes of ostomy pouching system undermining and leakage. Interventions to prevent recurrent undermining and leakage, usually focused on modifications of the pouching system, were completed when indicated.
CONCLUSIONS: For these 5 patients, complete resolution of peristomal MASD was observed at 2 to 8 days following CLSP treatment. More severe peristomal MASD cases required 7 to 8 days for complete resolution while less severe peristomal MASD resolved within 2 to 3 days. Patients showed less frequent pouching system changes, healing of peristomal skin, and reduced peristomal MASD associated with the CLSP treatment and addressing underlying etiology. On a pain scale of 0 to 10, patients reported less pain with an average of more than 7 out of 10 prior to the CLSP treatment and less than 4 out of 10 after treatment.
摘要：
背景：尽管造口护理最近取得了进展，造口和造口周围皮肤并发症(包括造口周围水分相关皮肤损伤(MASD))的发生率仍然高达80%。我们评估了一种氰基丙烯酸酯液体皮肤保护剂（CLSP），用于回肠造口术患者的造口周围MASD的治疗和愈合，回肠导管,或者结肠造口术.
方法：5例（24-85岁）与回肠造口术相关的造口周围MASD患者（n=2），回肠导管（n=2），或结肠造口术（n=1）在本病例研究中进行了评估。所有患者均采用CLSP治疗，以减少因流出物泄漏引起的造口周围MASD。导致口周皮肤的疼痛性剥脱。所有患者在更换袋装系统之前接受1至2次CLSP的应用。在CLSP申请之前，对患者进行评估，重点关注造口术袋系统破坏和渗漏的原因。防止反复破坏和渗漏的干预措施,通常专注于装袋系统的修改，在指示时完成。
结论：对于这5名患者，在CLSP治疗后2~8天观察到造口周围MASD完全消退.较严重的造口周围MASD病例需要7至8天才能完全消退，而较不严重的造口周围MASD在2至3天内消退。患者表现出不那么频繁的袋装系统变化，造口周围皮肤愈合，与CLSP治疗和解决潜在病因相关的造口周围MASD减少。在0至10的疼痛量表上,患者报告的疼痛较少,在CLSP治疗前10分之7以上,治疗后10分之4以下。
方法：5例（24-85岁）与回肠造口术相关的造口周围MASD患者（n=2），回肠导管（n=2），或结肠造口术（n=1）在本病例研究中进行了评估。所有患者均采用CLSP治疗，以减少因流出物泄漏引起的造口周围MASD。导致口周皮肤的疼痛性剥脱。所有患者在更换袋装系统之前接受1至2次CLSP的应用。在CLSP申请之前，对患者进行评估，重点关注造口术袋系统破坏和渗漏的原因。防止反复破坏和渗漏的干预措施,通常专注于装袋系统的修改，在指示时完成。
结论：对于这5名患者，在CLSP治疗后2~8天观察到造口周围MASD完全消退.较严重的造口周围MASD病例需要7至8天才能完全消退，而较不严重的造口周围MASD在2至3天内消退。患者表现出不那么频繁的袋装系统变化，造口周围皮肤愈合，与CLSP治疗和解决潜在病因相关的造口周围MASD减少。在0至10的疼痛量表上,患者报告的疼痛较少,在CLSP治疗前10分之7以上,治疗后10分之4以下。
